GH secretagogues
Cardiac effects of hexarelin in hypopituitary adults
Broglio F, Benso A, Valetto MR, et al. · Eur J Pharmacol · 1999
PMID: 10528131 · DOI: 10.1016/S0014-2999(99)00498-7
Summary
Acute pharmacodynamic study of hexarelin in hypopituitary adults vs healthy controls characterizing cardiac response. Endpoints: left ventricular ejection fraction by echocardiography, GH response.
Citation hosted by NCBI. We link to the source so the researcher can read the abstract, full text, or references-cited list directly.
More GH secretagogues citations
- Ipamorelin, the first selective growth hormone secretagogueEur J Endocrinol · 1998
- Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in ratsGrowth Horm IGF Res · 1999
- Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adultsJ Clin Endocrinol Metab · 2006